Testing effectiveness (Phase 2)Study completedNCT02278471What this trial is testingThe SCCS Polypill Pilot TrialWho this might be right forHypertensionHyperlipidemia Vanderbilt University 303
Testing effectiveness (Phase 2)Study completedNCT06822946What this trial is testingZhibitai Capsules for the Treatment of Primary HyperlipidemiaWho this might be right forPrimary Hyperlipidemia Chengdu Diao Jiuhong Pharmaceutical Factory 201
Very early researchStudy completedNCT05682911What this trial is testingProtective Effect of Zingiber Officinale L. Extract in Hypertensive PatientsWho this might be right forThe Main Focus of This Study is to Evaluate the Safety of Zingiber Officinale L. Tablets as Hypolipidemic Agent in Hypertensive Patients Jinnah Sindh Medical University 40
Post-approval studies (Phase 4)Study completedNCT06925100What this trial is testingInvestigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in TaiwanWho this might be right forPrimary Hypercholesterolemia or Mixed Hyperlipidemia Daiichi Sankyo 180
Large-scale testing (Phase 3)Study completedNCT05970679What this trial is testingClinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125AWho this might be right forHypercholesterolemia, Dyslipidemia Daewon Pharmaceutical Co., Ltd. 252
Not applicableStudy completedNCT01586897What this trial is testingThe Medication Metronome Project - Study to Facilitate Follow-up Testing Resulting From Prescribed Medications to Improve Patient Safety and CareWho this might be right forDiabetes Mellitus, Type 2HypertensionHyperlipidemia Massachusetts General Hospital 52
Post-approval studies (Phase 4)Study completedNCT01256476What this trial is testingPrevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed DyslipidemiaWho this might be right forPrimary DyslipidemiaMixed Dyslipidemia Kowa Research Institute, Inc. 328
Post-approval studies (Phase 4)Study completedNCT00652847What this trial is testingRandomized Parallel Group Trial Of The Efficacy And Safety Of Ezetimibe With A Statin Versus Statin Dose Doubling In Patients With Persistent Primary Hypercholesterolemia (0653-152)(COMPLETED)Who this might be right forHypercholesterolemia Organon and Co 1,140
Large-scale testing (Phase 3)Looking for participantsNCT07421297What this trial is testingEvaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed HyperlipidemiaWho this might be right forNon-familial Hypercholesterolemia and Mixed Hyperlipidemia CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 760
Large-scale testing (Phase 3)Not Yet RecruitingNCT07441317What this trial is testingQLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C)Who this might be right forPrimary Hypercholesterolemia or Mixed Hyperlipidemia Qilu Pharmaceutical Co., Ltd. 780
Not applicableStudy completedNCT01995149What this trial is testingEffect of Weight Loss on Cholesterol Metabolism in Hereditary Hypercholesterolemias and Overweight or Obesity.Who this might be right forFamilial HypercholesterolemiasWeight LossFamilial Combined Hypercholesterolemia+1 more Instituto Aragones de Ciencias de la Salud 78
Large-scale testing (Phase 3)Study completedNCT05888103What this trial is testingEfficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.Who this might be right forPrimary Hypercholesterolemia or Mixed Dyslipidemia Novartis Pharmaceuticals 207
Not applicableUnknownNCT03428061What this trial is testingThe ZWOlle Transmural Integrated Care for CArdiovaScular Risk Management StudyWho this might be right forCardiovascular DiseasesHypercholesterolemiaHypertension UMC Utrecht 740
Large-scale testing (Phase 3)Study completedNCT00249249What this trial is testingStudy to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol LevelsWho this might be right forPrimary HypercholesterolemiaDyslipidemia Kowa Research Europe 830
Testing effectiveness (Phase 2)Study completedNCT00776321What this trial is testingEprotirome for the Treatment of Dyslipidemia, Efficacy and Safety 12-Week, Phase ii Study to Assess the Safety and Efficacy of KB2115 in Patients With Primary HypercholesterolemiaWho this might be right forPrimary Hypercholesterolemia Karo Bio AB 142
Large-scale testing (Phase 3)Study completedNCT00376584What this trial is testingEffect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED)Who this might be right forHypercholesteremiaHyperlipidemia Merck Sharp & Dohme LLC 825
Post-approval studies (Phase 4)Active Not RecruitingNCT06249165What this trial is testingVictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart DiseaseWho this might be right forAtherosclerotic Cardiovascular Disease Duke University 130
Not applicableActive Not RecruitingNCT04579367What this trial is testingTreatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed DyslipidemiaWho this might be right forHypercholesterolemiaMixed Dyslipidemia Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 5,000
Not applicableStudy completedNCT00660764What this trial is testingAssessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)Who this might be right forHypercholesterolemiaCoronary Heart DiseasePeripheral Vascular Disease+2 more AstraZeneca
Large-scale testing (Phase 3)Ended earlyNCT02260635What this trial is testingEvacetrapib (LY2484595) in Japanese Participants With Primary HypercholesterolemiaWho this might be right forHypercholesterolemia Eli Lilly and Company 54